Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells

Abstract excerpt

Cell-based therapy for Duchenne muscular dystrophy patients and mdx mice has proven to be a safe but ineffective form of treatment. Recently, a group of cells called muscle side population (SP) cells have been isolated based on their ability to efflux the DNA-binding dye Hoechst. To understand the potential of skeletal muscle SP cells to serve as precursors for muscle, SP cells from the two mice strains mdx(5cv)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mesenchymal stem cell research
• Share to Muscle Physiology and Disorders
• Share to Tissue Engineering and Regenerative Medicine